Global Tardive Dyskinesia Treatment Market 2019-2023

  • Published: Oct 2018
  • Pages: 112
  • SKU: IRTNTR30055
Technavio

The 2021-2025 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global tardive dyskinesia treatment market is forecasted to experience a meteoric rise by 2023 driven by the increasing R&D on VMAT2 inhibitors. Wondering how to make the most of this flourishing tardive dyskinesia industry? Technavio’s extensive industry research report offers a detailed insight that will allow you to take full advantage of the opportunities available to you. This study provides an in-depth analysis of the market by considering the evolving demographics and consumer behavior in the global tardive dyskinesia treatment market. It also examines the competitive landscape and some key tardive dyskinesia treatment vendors that include F. Hoffmann-La Roche, Merck, and Neurocrine Biosciences.

Want to get a preview about how you can gain valuable insights from Technavio's market research report? Check out the latest facts about the tardive dyskinesia treatment industry

The global tardive dyskinesia treatment market is expected to grow at a CAGR of more than 4% during the forecast period

Tardive dyskinesia treatment industry growth is expected to accelerate over the next five years, driven by increasing use of antipsychotic drugs across the globe. There has been a significant rise in the administration of antipsychotic drugs which is resulting in growing prevalence of tardive dyskinesia. The higher consumption of antipsychotic drugs leads to various deformities which is expected to boost the growth of the global tardive dyskinesia treatment market. Also, the rising incidences of mental disorders is fueling the demand for tardive dyskinesia treatment around the world. Technavio's tardive dyskinesia treatment industry analysis reveals promising markets around the world.

Want a bigger picture? Get a free sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

The Americas dominated the tardive dyskinesia treatment market by region

The global tardive dyskinesia treatment market was dominated by the Americas with a market share of over 67%, followed by EMEA and APAC. However, APAC is expected to witness a faster growth than EMEA and the Americas over the period of forecast. In addition, the Americas will drive around 63% of the growth for the global tardive dyskinesia treatment industry, while EMEA and APAC are also predicted to contribute significantly to the incremental growth in the forecast period.

Get more value with Technavio's subscription platform! Gain easy access to all Technavio's reports, along with on-demand services. Start your 14-day FREE trial

 

F. Hoffmann-La Roche, Merck, and Neurocrine Biosciences are among the leading tardive dyskinesia treatment vendors

The global tardive dyskinesia treatment market is forecasted to grow reasonably fragmented with the existence of many international and regional vendors who offer tardive dyskinesia treatment. Most of the established companies in the global tardive dyskinesia treatment market are focused on investing heavily on the development of therapeutics for tardive dyskinesia treatment which will contribute to the growth of the market. Many international and regional vendors are vying for their share of the global tardive dyskinesia treatment market, and players must differentiate themselves to gain vital traction over their peers.

This report offers a complete analysis of several companies, including:

  • F. Hoffmann-La Roche
  • Merck
  • Neurocrine Biosciences
  • Novartis
  • Teva Pharmaceutical

Want to dial in on a specific region or segment? We can help! Our analysts can customize this report to meet your requirements. Get in touch

 

Read More Read Less

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Reports 2019
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>